This prospective randomized controlled trial evaluates whether intraoperative binaural beats reduce the remimazolam dose required for general anesthesia in 88 adults undergoing breast surgery. Patients are assigned to binaural beats or silent earphones, and the primary outcome is total intraoperative remimazolam consumption.
Adult patients (≥19 years old) scheduled to undergo breast surgery with reconstruction under general anesthesia.
Patients with hearing impairment, hearing loss, or those using hearing aids
Patients with external auditory canal disease that prevents wearing earphones
Patients with chronic use of hypnotics or sedatives
Patients with a history of obstructive sleep apnea or a BMI ≥ 35 kg/m²